Giving Compass' Take:
- Jaxx Artz covers how the latest trials show that a recently developed malaria vaccine is highly effective against the disease which kills thousands of people each year.
- What areas of the world experience disproportionate deaths from malaria? What systemic change is needed to prevent these deaths?
- Learn about what a lasting solution to malaria could look like.
What is Giving Compass?
We connect donors to learning resources and ways to support community-led solutions. Learn more about us.
The Jenner Institute of Oxford University announced that during their phase two trials concerning 450 children in Burkina Faso over 12 months, the vaccine achieved 77% efficacy, surpassing the World Health Organization’s (WHO) goal of 75% efficacy, according to the Guardian.
Malaria is a deadly disease caused by parasites transmitted to people through the bites of infected mosquitoes, which kills an estimated 400,000 children every year. In 2019, there were around 229 million cases reported around the world, with 94% of malaria cases and deaths on the African continent.
Malaria No More, a nonprofit organization that aims to end death caused by malaria, says that malaria costs less than £1 to treat, but devastates health systems and costs the African economy more than $12 billion every year.
“We can end malaria in our generation but only if governments invest in the research needed to deliver the new medicines and products that can accelerate the end of this terrible disease,” said Gareth Jenkins, director of advocacy at Malaria No More UK, in a statement shared with Global Citizen.
Read the full article about efforts to prevent malaria by Jaxx Artz at Global Citizen.